期刊文献+
共找到1,489篇文章
< 1 2 75 >
每页显示 20 50 100
急性脑梗死患者血清CXCL16水平与卒中亚型的关系 被引量:8
1
作者 张静静 潘旭东 +2 位作者 马爱军 王遐 王琨 《国际脑血管病杂志》 北大核心 2010年第11期818-822,共5页
目的 探讨急性脑梗死患者血清CXCL16水平变化及其与脑梗死TOAST病因学分型之间的关系.方法 应用酶联免疫吸附法检测113例急性脑梗死患者血清CXCL16水平,按TOAST分型进行分组,将各亚组之间以及与32例健康对照者进行比较.结果 病例组血清C... 目的 探讨急性脑梗死患者血清CXCL16水平变化及其与脑梗死TOAST病因学分型之间的关系.方法 应用酶联免疫吸附法检测113例急性脑梗死患者血清CXCL16水平,按TOAST分型进行分组,将各亚组之间以及与32例健康对照者进行比较.结果 病例组血清CXCL16水平显著高于对照组[(2.29±0.21)ng/ml对(1.75±0.21)ng/ml,t=12.863,P=0.000];大动脉粥样硬化性卒中组血清CXCL16水平显著高于小动脉闭塞性卒中组[(2.38±0.23)ng/ml对(2.21±0.11)ng/ml,q=5.743,P=0.000],而且两者均显著高于对照组(q=20.501,P=0.000;q=13.527,P=0.000).在大动脉粥样硬化性卒中组中,≥2条动脉狭窄组血清CXCL16水平与仅有1条动脉狭窄组无显著差异[(2.34±0.24)ng/ml对(2.46±0.19)ng/ml,t=-1.969,P=0.054].多变量logistic回归分析显示,CXCL16(OR=0.972,95% CI 0.956~0.978,P=0.001)和高脂血症(OR=3.547,95% CI1.160~10.848,P=0.020)足脑梗死发生的独立危险因素.结论 血清CXCL16水平在脑梗死急性期升高,与脑梗死发生密切相关,且大动脉粥样硬化性卒中组显著高于小动脉闭塞性卒中组. 展开更多
关键词 脑梗死 炎症趋化因子类 CXC cxcl 16蛋白 动脉粥样硬化 危险因素
原文传递
冠心病不稳定心绞痛治疗前后血清趋化因子CXCL 16检测的临床意义 被引量:5
2
作者 祝盛善 王庆春 胡坚 《临床合理用药杂志》 2015年第8期88-89,共2页
目的探讨冠心病不稳定心绞痛治疗前后血清CXCL 16水平的变化及意义。方法应用酶联免疫吸附法(ELISA)对51例冠心病不稳定心绞痛患者进行了治疗前后血清CXCL 16水平检测,并以35名正常健康人作比较。结果冠心病不稳定心绞痛患者在治疗前血... 目的探讨冠心病不稳定心绞痛治疗前后血清CXCL 16水平的变化及意义。方法应用酶联免疫吸附法(ELISA)对51例冠心病不稳定心绞痛患者进行了治疗前后血清CXCL 16水平检测,并以35名正常健康人作比较。结果冠心病不稳定心绞痛患者在治疗前血清CXCL 16水平显著高于正常人组,差异有统计学意义(P<0.01),经治疗6个月后,与治疗前有明显差异并与正常人比较,差异有统计学意义(P<0.05)。结论趋化因子CXCL 16在冠心病不稳定心绞痛的发病机制中具有重要的作用,有一定的临床价值。 展开更多
关键词 冠心病不稳定心绞痛 趋化因子 cxcl 16
下载PDF
膀胱尿路上皮癌中CXCL 13的表达与临床病理及预后的关系 被引量:4
3
作者 袁媛 陈庆丽 +1 位作者 李鹏超 杨潇 《广东医学》 CAS 2020年第2期200-203,共4页
目的探讨CXCL 13在膀胱尿路上皮癌组织中的表达与临床病理特征和预后的关系。方法通过免疫组化法检测77例膀胱尿路上皮癌和36例癌旁组织的石蜡标本中CXCL 13蛋白的表达,同时收集患者预后数据,并用统计学方法分析CXCL 13蛋白的表达与临... 目的探讨CXCL 13在膀胱尿路上皮癌组织中的表达与临床病理特征和预后的关系。方法通过免疫组化法检测77例膀胱尿路上皮癌和36例癌旁组织的石蜡标本中CXCL 13蛋白的表达,同时收集患者预后数据,并用统计学方法分析CXCL 13蛋白的表达与临床病理特征和预后的关系。结果CXCL 13在53例(68.8%)膀胱尿路上皮癌组织中呈阳性,而仅在10例(27.8%)正常膀胱组织中检测到阳性表达,膀胱尿路上皮癌组织中CXCL 13表达显著高于癌旁组织(P<0.01)。CXCL 13蛋白的表达与患者的淋巴结转移和临床分期有关(P<0.05);与性别、年龄、病理分级和病灶大小无关(P>0.05)。Kaplan-Meier生存分析显示膀胱尿路上皮癌患者肿瘤组织中CXCL 13蛋白阳性表达者的5年生存率低于阴性表达者(χ~2=5.423,P=0.020)。COX回归分析显示CXCL 13是膀胱尿路上皮癌患者的独立预后因素(Wald=4.923,HR=2.301,95%CI:1.102~4.803,P=0.026)。结论CXCL 13与膀胱尿路上皮癌的进展有关,CXCL 13可能在膀胱尿路上皮癌的发生及发展中发挥重要作用。 展开更多
关键词 膀胱尿路上皮癌 cxcl 13 免疫组化 预后
下载PDF
炎症因子在新生缺氧缺血性脑病大鼠脑组织中的表达及意义 被引量:1
4
作者 曾志涌 卢顺玉 +1 位作者 黎云鹏 邸伟 《中国现代医生》 2018年第28期38-41,共4页
目的探讨炎症因子在新生儿缺氧缺血性脑病(hypoxic-ischemic encephalopathy,HIE)大鼠脑组织中的表达及意义。方法 36只新生SD大鼠,随机分为对照组、缺血缺氧0 h、6 h、1 d、3 d、7 d组,每组6只。观察各组大鼠脑组织中TNF-α、CXCL10、C... 目的探讨炎症因子在新生儿缺氧缺血性脑病(hypoxic-ischemic encephalopathy,HIE)大鼠脑组织中的表达及意义。方法 36只新生SD大鼠,随机分为对照组、缺血缺氧0 h、6 h、1 d、3 d、7 d组,每组6只。观察各组大鼠脑组织中TNF-α、CXCL10、CXCL12、 IL-1α、IL-1β、IL-1R mRNA表达差异。结果 TNF-α在HIE发生后开始增高,6~24 h达到高峰后逐渐下降,72 h仍高于正常,而后下降,但仍高于对照组,至7 d后呈现低表达。CXCL10/12在0 h时表达与对照组对比未见差异,在6 h及12 h达到高峰,至72 h逐渐下降但仍高于对照组,至7 d时基本降至正常。相对对照组,IL-1R在整个HIE过程中未见明显高表达,而在疾病的初期及恢复期其发病早期却出乎意料的呈现低表达的特点(0 h、24 h、72 h),至7 d后恢复正常。IL-1α、IL-1β在0 h时期呈现低表达,6 h呈现高表达,而后在24 h后恢复正常,至7 d后IL-1α复又呈现低表达趋势。结论炎症因子与HIE发病进展密切相关,并且在疾病的不同进程中各种炎症因子起着不同的作用,可以作为判断疾病进展的客观指标。 展开更多
关键词 新生儿缺血缺氧性脑病 TNF-Α cxcl 白细胞介素
下载PDF
趋化因子CXCR4、CXCL5在肾透明细胞癌中的表达及临床意义 被引量:1
5
作者 李杰 沈雁冰 文秀华 《实用癌症杂志》 2021年第6期943-946,共4页
目的探究趋化因子CXCR4和CXCL5在肾透明细胞癌组织中的表达及其与TNM、组织学分级、淋巴结转移的相关性。方法选择肾透明细胞癌患者50例,比较癌组织和癌旁组织趋化因子CXCR4和CXCL5的表达水平以及与临床特征的相关性。结果癌组织的CXCR4... 目的探究趋化因子CXCR4和CXCL5在肾透明细胞癌组织中的表达及其与TNM、组织学分级、淋巴结转移的相关性。方法选择肾透明细胞癌患者50例,比较癌组织和癌旁组织趋化因子CXCR4和CXCL5的表达水平以及与临床特征的相关性。结果癌组织的CXCR4、CXCL5表达水平均显著高于癌旁组织(P<0.001)。CXCR4和CXCL5在TNM分期Ⅲ、Ⅳ期的阳性表达率显著高于Ⅰ、Ⅱ期(P=0.03);CXCR4和CXCL5在低分化组织中的阳性表达率显著高于中、高分化组织(P=0.03、0.02);CXCR4、CXCL5在有淋巴转移的患者中阳性表达率显著高于无淋巴转移的患者(P=0.03、0.02)。CXCR4与CXCL5在肾透明细胞癌组织中表达呈正相关(P=0.001)。结论CXCR4和CXCL5与肾透明细胞癌患者的TNM分期、组织学分级和淋巴结转移等方面有极大相关性,是评估患者病情和预后的有效指标。 展开更多
关键词 CXCR4 cxcl 肾透明细胞癌 TNM 组织学分级
下载PDF
趋化因子CXC亚家族及其与肿瘤的生物学关系
6
作者 朱庆超 汪昱 《国际外科学杂志》 2010年第10期693-697,共5页
趋化因子是一类具有化学趋化功能的多肽,CXC类趋化因子是趋化因子大家族中的一个亚族;在肿瘤细胞的发生、发展中常伴随着一系列的分子生物学改变,趋化因子CXC亚家族与机体对肿瘤的免疫应答及其与生物学之间有着密切的关系。本文就趋... 趋化因子是一类具有化学趋化功能的多肽,CXC类趋化因子是趋化因子大家族中的一个亚族;在肿瘤细胞的发生、发展中常伴随着一系列的分子生物学改变,趋化因子CXC亚家族与机体对肿瘤的免疫应答及其与生物学之间有着密切的关系。本文就趋化因子CXC亚族中的几个成员及其受体与肿瘤的生物学关系进行综述。 展开更多
关键词 趋化因子 cxcl 受体 肿瘤
原文传递
CHRM3 is a novel prognostic factor of poor prognosis andpromotes glioblastoma progression via activation of oncogenicinvasive growth factors
7
作者 BIN ZHANG JIANYI ZHAO +7 位作者 YONGZHI WANG HUA XU BO GAO GUANGNING ZHANG BIN HAN GUOHONG SONG JUNCHEN ZHANG WEI MENG 《Oncology Research》 SCIE 2023年第6期917-927,共11页
Glioblastoma(GBM)is the most aggressive cancer of the brain and has a high mortality rate due to the lack of effective treatment strategy.Clarification of molecular mechanisms of GBM’s characteristic invasive growth ... Glioblastoma(GBM)is the most aggressive cancer of the brain and has a high mortality rate due to the lack of effective treatment strategy.Clarification of molecular mechanisms of GBM’s characteristic invasive growth is urgently needed to improve the poor prognosis.Single-nuclear sequencing of primary and recurrent GBM samples revealed that levels of M3 muscarinic acetylcholine receptor(CHRM3)were significantly higher in the recurrent samples than in the primary samples.Moreover,immunohistochemical staining of an array of GBM samples showed that high levels of CHRM3 correlated with poor prognosis,consistent with The Cancer Genome Atlas database.Knockdown of CHRM3 inhibited GBM cell growth and invasion.An assay of orthotopic GBM animal model in vivo indicated that inhibition of CHRM3 significantly suppressed GBM progression with prolonged survival time.Transcriptome analysis revealed that CHRM3 knockdown significantly reduced an array of classic factors involved in cancer invasive growth,including MMP1/MMP3/MMP10/MMP12 and CXCL1/CXCL5/CXCL8.Taken together,CHRM3 is a novel and vital factor of GBM progression via regulation of multiple oncogenic genes and may serve as a new biomarker for prognosis and therapy of GBM patients. 展开更多
关键词 GLIOBLASTOMA PROGNOSIS CHRM3 MMP cxcl
下载PDF
CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway
8
作者 Qi Yaking Li Yue Wang Weiqun 《解剖学杂志》 CAS 2021年第S01期201-202,共2页
CXCL3 belongs to the CXC-type chemokine family and is known to play a multifaceted role in various human malignancies.While it's clinical significance and mechanisms of action in uterine cervical cancer(UCC)remain... CXCL3 belongs to the CXC-type chemokine family and is known to play a multifaceted role in various human malignancies.While it's clinical significance and mechanisms of action in uterine cervical cancer(UCC)remain unclear.This investigation demonstrated that the UCC cell line HeL.a expressed CXCL3,and strong expression of CXCL3 was detected in UCC tissues relative to nontumor tissues.In addition,CXCL3 expression was strongly correlated with CXCL5 expression in UCC tissues.In vitro,HeLa cells overexpressing CXCL3,HeLa cells treated with exogenous CXCL3 or treated with conditioned medium from WPMY cells overexpresing CXCL3,exhibited enhanced proliferation and migration activities. 展开更多
关键词 cxcl CERVICAL UTERINE
下载PDF
Cxcl16 Interact With SARS-CoV N Protein In and Out Cell
9
作者 Yuan-peng ZHANG Rong-wu ZHANG +1 位作者 Wei-shan CHANG Yan-yanWANG 《Virologica Sinica》 SCIE CAS CSCD 2010年第5期369-374,共6页
Our study investigated the host cell protein which can interact with SARS-CoV N protein, and explored the functional connections. The eukaryotic expression vectors pEGFP-N1/SARS-CoVN and pdsRed2-N1/ CXCL16 were constr... Our study investigated the host cell protein which can interact with SARS-CoV N protein, and explored the functional connections. The eukaryotic expression vectors pEGFP-N1/SARS-CoVN and pdsRed2-N1/ CXCL16 were constructed and used to co-transfect HEK293FT cells by the calcium phosphate method. The HIS-tagged fusion protein SARS-CoVN-GFP was then built and purified for the binding assay in vitro. The co-localization of SARS-CoVN and CXCL16 in the cytoplasm of HEK293FT cells was also shown using confocal laser scanning microscopy. It is suggested that their interaction might be through direct combination. Under a fluorescence microscope, it was observed that the purified fusion protein SARS-CoVN-GFP was attached to the cell membrane of CXCL16-transfected cells, indicating that SARS-CoVN and CXCL16 can be mutually combined. 展开更多
关键词 SARS-CoVN cxcl 16 Eukaryotic expression Confocal laser scanning
下载PDF
The role of CXCL chemokine family in the development and prognosis of colorectal cancer
10
作者 Jun Zhang Xue-Tao Wang Jing Xia 《Medical Data Mining》 2022年第3期47-58,共12页
Objective:Colorectal cancer(CRC)is a major cause of cancer-related deaths worldwide.The class of chemokines known as cysteine-x-cysteine(CXC)motif ligands(CXCL)is thought to have a significant role in inflammation.A p... Objective:Colorectal cancer(CRC)is a major cause of cancer-related deaths worldwide.The class of chemokines known as cysteine-x-cysteine(CXC)motif ligands(CXCL)is thought to have a significant role in inflammation.A previous study implicated that CXCL family may play a role in angiogenesis and tumor development.In this comprehensive study,16 CXCLs in CRC will be analyzed for their prognostic values and expression patterns.Methods:To investigate CXCLs expression,immune cell infiltration,prognostic value significance,and genetic alteration among CRC patients,Gene Expression Profiling Interactive Analysis 2(GEPIA2),Kaplan-Meier plotter(K-M plotter),Gene Set Cancer Analysis(GSCA),STRING,GeneMANIA,and Sangerbox3.0 were employed.Results:As a result of our study,there was a significant increase in the levels of CXCL1/2/3/4/5/8/9/10/11/13/14/16 in CRC tissues,whereas CXCL12 was reduced.The expression of CXCL1/2/3/9/10/11 in CRC was linked to tumor stage.High expression of CXCL2/3/14 was associated with longer overall survival(OS)in colon adenocarcinoma(COAD)patients,and the overexpression of CXCL2/6/9/11/13 was related to long OS in rectum adenocarcinoma(READ)patients.Additionally,patients with CRC who expressed high levels of CXCL9/10/11 tended to have a longer disease-free survival(DFS).Furthermore,the functions of differentially expressed CXCLs were mainly involved in cytokine activity and chemokine effects.A significant correlation has been found between CXCLs expression and the infiltration of diverse immune cells in COAD and READ,including six types of CD4+T cells,macrophages,neutrophils,B cells,CD8+T cells,and dendritic cells.Conclusions:According to our study,CXCLs may not only serve as prognostic markers for CRC patients but also affect the immune status of CRC tissues,thereby providing new ideas for immunotherapy. 展开更多
关键词 bioinformatics analysis cxcl chemokine family CRC BIOMARKER PROGNOSIS
下载PDF
The CXCL12(SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy 被引量:37
11
作者 ZHOU Yu CAO Han-Bo +1 位作者 LI Wen-Jun ZHAO Li 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2018年第11期801-810,共10页
Chemokine 12(CXCL12), also known as stromal cell derived factor-1(SDF-1) and a member of the CXC chemokine subfamily, is ubiquitously expressed in many tissues and cell types. It interacts specifically with the ligand... Chemokine 12(CXCL12), also known as stromal cell derived factor-1(SDF-1) and a member of the CXC chemokine subfamily, is ubiquitously expressed in many tissues and cell types. It interacts specifically with the ligand for the transmembrane G protein-coupled receptors CXCR4 and CXCR7. The CXCL12/CXCR4 axis takes part in a series of physiological, biochemical, and pathological process, such as inflammation and leukocyte trafficking, cancer-induced bone pain, and postsurgical pain, and also is a key factor in the cross-talking between tumor cells and their microenvironment. Aberrant overexpression of CXCR4 is critical for tumor survival, proliferation, angiogenesis, homing and metastasis. In this review, we summarized the role of CXCL12/CXCR4 in cancer, CXCR4 inhibitors under clinical study, and natural product CXCR4 antagonists. In conclusion, the CXCL12/CXCR4 signaling is important for tumor development and targeting the pathway might represent an effective approach to developing novel therapy in cancer treatment.Chemokine 12(CXCL12), also known as stromal cell derived factor-1(SDF-1) and a member of the CXC chemokine subfamily, is ubiquitously expressed in many tissues and cell types. It interacts specifically with the ligand for the transmembrane G protein-coupled receptors CXCR4 and CXCR7. The CXCL12/CXCR4 axis takes part in a series of physiological, biochemical, and pathological process, such as inflammation and leukocyte trafficking, cancer-induced bone pain, and postsurgical pain, and also is a key factor in the cross-talking between tumor cells and their microenvironment. Aberrant overexpression of CXCR4 is critical for tumor survival, proliferation, angiogenesis, homing and metastasis. In this review, we summarized the role of CXCL12/CXCR4 in cancer, CXCR4 inhibitors under clinical study, and natural product CXCR4 antagonists. In conclusion, the CXCL12/CXCR4 signaling is important for tumor development and targeting the pathway might represent an effective approach to developing novel therapy in cancer tr 展开更多
关键词 cxcl12/CXCR4 Tumor Targeted therapy PLERIXAFOR
原文传递
The unique structural and functional features of CXCL12 被引量:35
12
作者 Rik Janssens Sofie Struyf Paul Proost 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2018年第4期299-311,共13页
The CXC chemokine CXCL12 is an important factor in physiological and pathological processes, includingembryogenesis, hematopoiesis, angiogenesis and inflammation, because it activates and/or induces migration ofhemato... The CXC chemokine CXCL12 is an important factor in physiological and pathological processes, includingembryogenesis, hematopoiesis, angiogenesis and inflammation, because it activates and/or induces migration ofhematopoietic progenitor and stem cells, endothelial cells and most leukocytes. Therefore, CXCL12 activity istightly regulated at multiple levels. CXCL12 has the unique property of existing in six splice variants in humans,each having a specific tissue distribution and in vivo activity. Controlled splice variant transcription and mRNAstability determine the CXCL12 expression profile. CXCL12 fulfills its functions in homeostatic and pathologicalconditions by interacting with its receptors CXC chemokine receptor 4 (CXCR4) and atypical chemokine receptor 3(ACKR3) and by binding to glycosaminoglycans (GAGs) in tissues and on the endothelium to allow a properpresentation to passing leukocytes. Homodimerizaton and heterodimerization of CXCL12 and its receptors can altertheir signaling activity, as exemplified by the synergy between CXCL12 and other chemokines in leukocyte migrationassays. Receptor binding may also initiate CXCL12 internalization and its subsequent removal from theenvironment. Furthermore, CXCL12 activity is regulated by posttranslational modifications. Proteolytic removal ofNH2- or COOH-terminal amino acids, citrullination of arginine residues by peptidyl arginine deiminases or nitrationof tyrosine residues reduce CXCL12 activity. This review summarizes the interactions of CXCL12 with the cellularenvironment and discusses the different levels of CXCL12 activity regulation. 展开更多
关键词 ACKR3 CHEMOKINE cxcl12 CXCR4 REGULATION
原文传递
苏子降气汤对慢性阻塞性肺疾病急性发作期(痰浊壅肺证)肺功能的影响及部分机制 被引量:34
13
作者 郑忻 曲妮妮 +2 位作者 马丽佳 秦一冰 徐欣 《世界中医药》 CAS 2018年第6期1487-1491,共5页
目的:观察苏子降气汤对慢性阻塞性肺疾病急性发作期(痰浊壅肺证)患者肺功能和生命质量的影响,并探讨其部分机制。方法:选取2015年1月至2017年5月辽宁中医药大学附属医院呼吸内科住院的AECOPD(痰浊壅肺证)患者共108例,通过随机数字表法将... 目的:观察苏子降气汤对慢性阻塞性肺疾病急性发作期(痰浊壅肺证)患者肺功能和生命质量的影响,并探讨其部分机制。方法:选取2015年1月至2017年5月辽宁中医药大学附属医院呼吸内科住院的AECOPD(痰浊壅肺证)患者共108例,通过随机数字表法将108例患者按照随机编号分成对照组与观察组,每组54例;观察组:在对照组西药治疗的基础上根据中医辨证论治予苏子降气汤口服。根据量化的中医证候评分变化、肺功能和生命质量观察苏子降气汤对AECOPD(痰浊壅肺证)的影响,并采用酶联免疫吸附试验(ELISA)法检测IL-21和CXCL13的水平。结果:与治疗前比较,2组中医证候评分明显降低(P<0.05),且观察组治疗后的中医证候评分明显低于对照组(P<0.05)。治疗后2组肺功能均较治疗前有所提高,然而观察组肺功能的主要指标FVC(L)、FEV_1(L)、FEV_1/FVC(%)和PEF(L/s)明显优于对照组(P<0.05)。治疗后观察组生命质量评定症状、活动、影响和平均分均显著低于对照组(P<0.05)。治疗后IL-21和CXCL13的表达水平2组均明显下降(P<0.05),且观察组优于对照组(P<0.05)。结论:苏子降气汤可明显改善AECOPD(痰浊壅肺证)患者的病情,提高患者的肺功能及生命质量,其作用机制可能与降低外周血IL-21及CXCL13水平有关。 展开更多
关键词 苏子降气汤 痰浊壅肺证 慢性阻塞性肺疾病 肺功能 生命质量 白细胞介素-21 趋化因子13
下载PDF
Roles of Chemokine Receptor 4 (CXCR4) and Chemokine Ligand 12 (CXCL12) in Metastasis of Hepatocellular Carcinoma Cells 被引量:30
14
作者 Hui Liu Zeya Pan Aijun Li Siyuan Fu Yin Lei Hangyong Sun Mengchao Wu Weiping Zhou 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2008年第5期373-378,共6页
Chemokines are involved in human hepatocellular carcinoma (HCC) carcinogenesis. However, the exact mechanism of chemokines in HCC carcinogenesis remains unknown. Here we investigated the roles of chemokine receptor... Chemokines are involved in human hepatocellular carcinoma (HCC) carcinogenesis. However, the exact mechanism of chemokines in HCC carcinogenesis remains unknown. Here we investigated the roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in the metastasis of HCC. We found that the expression levels of CXCR4 mRNA in HCC tissues, MHCC97 cells, and HUVEC cells were 2.52 ±1.13, 2.34 ±1.16 and 1.63 ±1.26, respectively and that the CXCR4 protein levels were 1.38 ± 0.13, 1.96± 0.32 and 1.86 ±0.21, respectively. In contrast, CXCR4 was not detected in normal hepatic tissues. In 78 HCC patients, we also found that the concentration of CXCL12 in cancerous ascitic fluid was 783-8,364 pg/ml and that CXCL12 mRNA level in HCC metastasis portal lymph nodes was 1.21 ± 0.87 but undetectable in normal hepatic tissues. Finally we discovered that recombinant human CXCL12 could induce MHCC97 cells and HUVEC cells to migrate with chemotactic indexes (CI) of 3.9 ±1.1 and 4.1± 1.6, respectively. Cancerous ascitic fluid could also induce the migration of MHCC97 cells with a CI of 1.9 ± 0.8. Thus, our data suggest that CXCR4 and CXCL12 may play an important role in the metastasis of HCC by promoting the migration of tumor cells. 展开更多
关键词 CXCR4 cxcl12 hepatocellular carcinoma migration METASTASIS
原文传递
多指标联合检测的液态悬浮芯片技术在卵巢恶性肿瘤诊断中的应用 被引量:28
15
作者 赵冰冰 阳志军 +3 位作者 王琪 潘忠勉 张玮 李力 《中华妇产科杂志》 CAS CSCD 北大核心 2017年第1期11-19,共9页
目的探讨多指标联合检测的液态悬浮芯片技术在卵巢恶性肿瘤诊断中的应用。 方法收集2003年9月-2009年10月广西医科大学附属肿瘤医院收治的卵巢恶性肿瘤患者119例以及2007年4月-2010年9月本院收治的其他上皮性恶性肿瘤包括乳腺癌、肝癌... 目的探讨多指标联合检测的液态悬浮芯片技术在卵巢恶性肿瘤诊断中的应用。 方法收集2003年9月-2009年10月广西医科大学附属肿瘤医院收治的卵巢恶性肿瘤患者119例以及2007年4月-2010年9月本院收治的其他上皮性恶性肿瘤包括乳腺癌、肝癌、肺癌患者(均为女性)各40例(恶性肿瘤组),盆腔良性肿瘤患者204例(良性肿瘤组),以2008年在本院体检的健康妇女120例为正常对照组。(1)采用血清抗原抗体(包括CCL18、CXCL1抗原以及C1D、TM4SF1、FXR1、TIZ IgG型自身抗体)联合的液态悬浮芯片技术检测3组妇女血清CCL18、CXCL1抗原以及C1D、TM4SF1、FXR1、TIZ IgG型自身抗体的含量。(2)采用多因素logistic回归法逐步筛选相关性较好的指标并建立回归模型[即卵巢恶性肿瘤诊断模型和卵巢上皮性癌(卵巢癌)诊断模型],对模型进行数学验证和临床验证,并与血清CA125单独检测的诊断效能进行比较。(3)比较血清抗原抗体联合检测、自身抗体谱(包括C1D、TM4SF1、FXR1、TIZ IgG型自身抗体)联合检测、CA125单独检测对早期(Ⅰ~Ⅱ期)卵巢恶性肿瘤的诊断效能。(4)比较血清抗原抗体联合检测、CA125单独检测对不同病理类型和病理分化程度的卵巢恶性肿瘤的诊断阳性率。 结果(1)恶性肿瘤组患者血清CCL18、CXCL1抗原以及C1D、TM4SF1、FXR1、TIZ IgG型身抗体的含量分别为(228±100)μg/L、(247±84)ng/L、(140±95)μg/L、(182±148)μg/L、(230±106)μg/L、(190±98)μg/L,明显高于良性肿瘤组和正常对照组(P均〈0.01)。(2)经logistic回归法逐步筛选,建立血清抗原抗体联合检测的卵巢恶性肿瘤诊断模型和血清自身抗体谱联合检测的卵巢癌诊断模型,其模型分别为:logit(P)=-11.151+0.008×C1D+0.011×TM4SF1+0.011×TIZ-0.008×FXR1+0.021×CCL18+0.200×CXCL1,logit(P)=-5.137+0.013×C1D+0.014 展开更多
关键词 卵巢肿瘤 趋化因子 CC 趋化因子cxcl1 抗原 表面 肿瘤蛋白质类 自身抗体 生物学标记
原文传递
半夏泻心汤对Hp阳性慢性萎缩性胃炎小鼠趋化因子CXCL9、CXCL10及炎性因子的影响 被引量:27
16
作者 李慧臻 王天麟 +2 位作者 马佳乐 刘琳 孔祥茹 《时珍国医国药》 CAS CSCD 北大核心 2021年第10期2316-2320,共5页
目的研究半夏泻心汤对Hp阳性慢性萎缩性胃炎(Chronic atrophic gastritis,CAG)小鼠胃组织及血清中趋化因子CXCL9、CXCL10及炎性因子IL-17A、IL-6、IL-22的影响,揭示半夏泻心汤治疗Hp相关性胃炎的作用机制。方法将64只C57BL/6小鼠随机分... 目的研究半夏泻心汤对Hp阳性慢性萎缩性胃炎(Chronic atrophic gastritis,CAG)小鼠胃组织及血清中趋化因子CXCL9、CXCL10及炎性因子IL-17A、IL-6、IL-22的影响,揭示半夏泻心汤治疗Hp相关性胃炎的作用机制。方法将64只C57BL/6小鼠随机分为正常组10只、造模组54只。造模组予Hp菌液灌服、自由饮用MNNG溶液。8周后,随机抽取造模组4只小鼠检测是否造模成功。将已成模的50只Hp阳性CAG小鼠随机分为模型组、四联组、半夏泻心汤全方组、辛开组、苦降组各10只。正常组、模型组予生理盐水灌胃;四联组予四联杀菌药物灌胃;全方组予半夏泻心汤浓煎剂灌胃;辛开组予辛开汤浓煎剂灌胃;苦降组予苦降汤浓煎剂灌胃。ELISA检测小鼠趋化因子CXCL9、CXCL10及炎性因子IL-17A、IL-6、IL-22的表达。结果模型组小鼠可见胃黏膜层变薄,腺体数量减少、结构紊乱、排列形态扭曲,部分可见肠化、异型增生。药物干预后均不同程度的改善上述病理表现。与正常组对比,模型组小鼠胃组织及血清中CXCL-9、CXCL-10表达水平均升高(P<0.01)。与模型组对比,四联组、半夏泻心汤全方组干预后小鼠胃组织中CXCL-9、CXCL-10表达均下降(P<0.01或P<0.05),血清中仅四联组CXCL-10表达下降(P<0.01)。与正常组对比,模型组小鼠胃组织及血清中IL-17A、IL-6、IL-22表达水平均升高(P<0.01)。与模型组对比,四联组、半夏泻心汤全方组干预后小鼠胃组织及血清中IL-17A、IL-6、IL-22表达均下降(P<0.01或P<0.05)。辛开组、苦降组干预后小鼠胃组织及血清中CXCL-9、CXCL-10及IL-17A、IL-6、IL-22表达有不同程度的下降。结论Hp阳性CAG小鼠胃组织及血清中CXCL9、CXCL10表达均明显升高,半夏泻心汤及四联杀菌法可通过调控趋化因子CXCL9、CXCL10,降低炎性因子IL-17A、IL-6、IL-22表达,发挥治疗CAG的作用。 展开更多
关键词 半夏泻心汤 幽门螺杆菌相关性胃炎 趋化因子 cxcl9 cxcl10 炎性因子
原文传递
Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion 被引量:27
17
作者 Kawin Leelawat Surang Leelawat +1 位作者 Siriluck Narong Suradej Hongeng 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第10期1561-1568,共8页
AIM: To evaluate the expression of C-X-C motif chemokine receptor 4 (CXCR4) and its signaling cascades, which were previously identified as a key factor for cancer cell progression and metastasis, in cholangiocarci... AIM: To evaluate the expression of C-X-C motif chemokine receptor 4 (CXCR4) and its signaling cascades, which were previously identified as a key factor for cancer cell progression and metastasis, in cholangiocarcinoma cell lines. METHODS: The expression of CXCR4 and its signaling cascades were determined in the cholangiocarcinoma cell lines (RMCCA1 and KKU100) by Western blotting. The invasion assays and the detection of actin polymerization were tested in these cholangiocarcinoma cells treated with CXC chemokine ligand -12 (CXCL12). RESULTS: Expression of CXCR4 was detected in both cholangiocarcinoma cell lines and activation of CXCR4 with CXCL12 triggered the signaling via the extracellular signal-regulated kinase-1/2 (ERK1/2) and phosphoinositide 3-kinase (PI3K) and induction of cholangiocarcinoma cell invasion, and displayed high levels of actin polymerization. Addition of CXCR4 inhibitor (AMD3100) abrogated CXCL12-induced phosphorylation of MEKI/2 and Akt in these cells. Moreover, treatment with MEK1/2 inhibitor (U0126) or PI3K inhibitor (LY294002) also attenuated the effect of CXCL12- induced cholangiocarcinoma cell invasion. CONCLUSION: These results indicated that the activation of CXCR4 and its signaling pathways (MEK1/2 and Akt) are essential for CXCL12-induced cholangiocarcinoma cell invasion. This rises Implications on a potential role for the inhibition of CXCR4 or its signal cascades in the treatment of cholangiocarcinoma. 展开更多
关键词 CHOLANGIOCARCINOMA CXCR4 cxcl12 MEK1/2 PI3K
下载PDF
血必净注射液联合参附注射液治疗脓毒症效果探讨 被引量:27
18
作者 丁国娟 吕铁 《中国全科医学》 CAS CSCD 北大核心 2015年第11期1300-1303,共4页
目的探讨血必净注射液联合参附注射液对脓毒症患者临床疗效、血流动力学指标、血清巨噬细胞炎症蛋白2(MIP-2)、降钙素原(PCT)的影响。方法选取2012年1月—2014年1月绍兴市人民医院急诊重症监护室(EICU)收治的脓毒症患者68例,采用随机数... 目的探讨血必净注射液联合参附注射液对脓毒症患者临床疗效、血流动力学指标、血清巨噬细胞炎症蛋白2(MIP-2)、降钙素原(PCT)的影响。方法选取2012年1月—2014年1月绍兴市人民医院急诊重症监护室(EICU)收治的脓毒症患者68例,采用随机数字表法将患者分为对照组和观察组,各34例。两组患者均参照2008年国际脓毒性休克治疗指南进行治疗,观察组在此基础上给予血必净注射液联合参附注射液治疗。记录两组患者治疗前后序贯器官功能障碍评分(SOFA)及急性生理与慢性健康状况评分系统Ⅱ(APACHEⅡ)、肺损伤评分(Murray评分)、血流动力学〔红细胞沉降率(ESR)、纤维蛋白原(Fib)、低切变率下全血黏度(nbl)、高切变率下全血黏度(nbh)〕、MIP-2、PCT水平。结果治疗前,两组SOFA及APACHEⅡ、Murray评分比较,差异无统计学意义(P>0.05);治疗后,观察组SOFA及APACHEⅡ、Murray评分均低于对照组(P<0.05)。治疗前两组ESR、Fib、nbl和nbh比较,差异均无统计学意义(P>0.05);治疗后观察组ESR、Fib、nbl和nbh均低于对照组(P<0.05)。治疗前两组MIP-2和PCT比较,差异均无统计学意义(P>0.05);治疗后观察组MIP-2和PCT均低于对照组(P<0.05)。对照组不良反应发生率为5.9%(2/34),观察组不良反应发生率为8.8%(3/34),两组不良反应发生率比较,差异无统计学意义(χ2=0.216,P=0.642)。结论血必净注射液联合参附注射液治疗脓毒症能有效改善患者血流动力学指标,降低炎性因子水平,促进患者预后。 展开更多
关键词 脓毒症 血必净注射液 参附注射液 趋化因子cxcl2 降钙素原
下载PDF
乳移平配伍肺经引经药桔梗抗乳腺癌肺转移作用及机制的实验研究 被引量:26
19
作者 刘玲琳 刘胜 《上海中医药杂志》 2010年第10期61-65,共5页
目的从CXCL12/CXCR4生物学轴及癌基因HER-2角度出发,探讨"乳移平"配伍肺经引经药"桔梗"对人乳腺癌MDA-MB-435HM肺转移模型的抑制作用及机制。方法建立人乳腺癌细胞株MDA-MB-435HM肺转移模型,随机分为乳移平组、乳... 目的从CXCL12/CXCR4生物学轴及癌基因HER-2角度出发,探讨"乳移平"配伍肺经引经药"桔梗"对人乳腺癌MDA-MB-435HM肺转移模型的抑制作用及机制。方法建立人乳腺癌细胞株MDA-MB-435HM肺转移模型,随机分为乳移平组、乳移平配伍桔梗组、乳移平配伍川牛膝组、阿霉素组及对照组。给药期间测原位瘤长、短径。给药结束后称瘤重,计算瘤重抑制率;行原位瘤及肺组织病理并定量分析各组肺转移情况;原位杂交法测各组原位瘤及肺组织中CXCL12、CXCR4及HER-2mRNA的表达。结果乳移平、乳移平配伍桔梗和阿霉素组对MDA-MB-435HM荷瘤裸鼠原位瘤和肺转移的发生均有一定的抑制作用。与乳移平单方比,乳移平配伍桔梗后可进一步提高荷瘤裸鼠原位瘤抑制率3.79%以及降低肺转移发生率26.44%。与对照组比较,乳移平和乳移平配伍桔梗组均能下调原位瘤中CXCR4和肺组织中CXCL12的表达;与乳移平单方比,乳移平配伍桔梗后可进一步下调原位瘤中CXCL12和肺组织中HER-2的表达(P<0.01,P<0.05)。结论与乳移平单方比,乳移平配伍桔梗后可进一步抑制乳腺癌肺转移的发生、发展,其作用机制可能通过调节CXCL12/CXCR4生物学轴及癌基因HER-2实现。 展开更多
关键词 乳腺癌 肺转移 乳移平 桔梗 cxcl12/CXCR4轴 HER-2
下载PDF
急性脑梗死患者血清CXCL16 GDF15 Lp-PLA2水平变化及临床意义 被引量:25
20
作者 刘希奇 李孝庆 +3 位作者 姚彦 崔亚男 邵汝升 李猛 《河北医学》 CAS 2019年第3期580-584,共5页
目的:探讨急性脑梗死(ACI)患者血清CXCL16,GDF15,Lp-PLA2表达水平及其临床意义。方法:选取2016年1月至2018年3月我院收治的急性脑梗死患者100例(研究组)和同期健康体检者100例(对照组),收集患者的临床资料,并根据TOAST将ACI患者进行分... 目的:探讨急性脑梗死(ACI)患者血清CXCL16,GDF15,Lp-PLA2表达水平及其临床意义。方法:选取2016年1月至2018年3月我院收治的急性脑梗死患者100例(研究组)和同期健康体检者100例(对照组),收集患者的临床资料,并根据TOAST将ACI患者进行分组。采用酶联免疫吸附分析检测患者血清的CXCL16、GDF-15和Lp-PLA2水平,并进行统计学分析。结果:单变量分析显示,ACI组和对照组在高血压、糖尿病、高脂血症、CXCL16、GDF15和Lp-PLA2水平上有显著性差异(P <0.05)。ACI患者血清CXCL16水平与BMI(P=0.001)、高血压(P=0.018)、高脂血症(P=0.044)和入院时NIHSS评分(P=0.004)有关; GDF15与糖尿病(P=0.042)、高脂血症(P=0.005)和入院时NIHSS评分(P=0.003)有关; Lp-PLA2与BMI(P=0.046)、高脂血症(P=0.040)和入院时NIHSS评分(P=0.046)有关。与其他ACI亚型相比,大动脉粥样硬化型(LAA)患者血清CXCL16、GDF15、Lp-PLA2水平最高(分别为3.64±0.63、1338.12±513.31、344.52±134.26),且有统计学差异(P<0.05)。结论:血清CXCL16、GDF-15和Lp-PLA2水平升高是急性缺血性卒中的危险因素。 展开更多
关键词 急性脑梗死 cxcl16 GDF15 LP-PLA2 危险因素
下载PDF
上一页 1 2 75 下一页 到第
使用帮助 返回顶部